Opthea

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Opthea and other ETFs, options, and stocks.

About OPT

Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. 

CEO
Frédéric Guerard
CEOFrédéric Guerard
Employees
—
Employees—
Headquarters
South Yarra, Victoria (VIC)
HeadquartersSouth Yarra, Victoria (VIC)
Founded
1984
Founded1984
Employees
—
Employees—

OPT Key Statistics

Market cap
295.60M
Market cap295.60M
Price-Earnings ratio
-1.54
Price-Earnings ratio-1.54
Dividend yield
—
Dividend yield—
Average volume
4.73K
Average volume4.73K
High today
$3.50
High today$3.50
Low today
$3.49
Low today$3.49
Open price
$3.50
Open price$3.50
Volume
1.86K
Volume1.86K
52 Week high
$4.42
52 Week high$4.42
52 Week low
$1.60
52 Week low$1.60
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.